Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

Nanomedicine in 2026 will emphasize safe scale-up and mechanistically aware therapies, bridging the gap between research and ...

For the first time,” he wrote in a leaked email to his staff, “the US FDA will acknowledge that COVID-19 vaccines have killed ...

We came across a bullish thesis on Novavax, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

We came across a bullish thesis on CureVac N.V. on Ridire Research’s Substack. In this article, we will summarize the bulls’ ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...

Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...